BIW-8962

BIW-8962 · Kyowa Kirin Korea Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BIW-8962, covering 2024-04-25 to 2024-04-25. Get the full timeline:

Most recent: Clinical Trial Update: Two-Part, Open-Label, Multi-Center, Phase 1/2 Study of BIW-8962 as Monotherapy in Subjects With Lung Cancer [Phase 1, Phase 2]

See pricing